Comparative characteristics of early-onset vs. late-onset advanced colorectal cancer: a nationwide study in China
Hongwei Liu,
Huifang Xu,
Yin Liu,
Yuqian Zhao,
Xi Zhang,
Yanqin Yu,
Lingbin Du,
Yunyong Liu,
Wenjun Wang,
Helu Cao,
Li Ma,
Juanxiu Huang,
Ji Cao,
Li Li,
Yanping Fan,
Xiaofen Gu,
Changyan Feng,
Qian Zhu,
Xiaohui Wang,
Jingchang Du,
Shaokai Zhang,
Youlin Qiao
Affiliations
Hongwei Liu
Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Huifang Xu
Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Yin Liu
Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Yuqian Zhao
Office of Academic Research, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China
Xi Zhang
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute
Yanqin Yu
The Clinical Epidemiology of Research Center, Department of Dermatological, The First Affiliated Hospital of Baotou Medical College
Lingbin Du
Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital
Yunyong Liu
Office of Shenzhen Cancer Prevention and Control Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Wenjun Wang
School of Nursing, Jining Medical University
Helu Cao
Department of Preventive Health, Xinxiang Central Hospital
Li Ma
Public Health School, Dalian Medical University
Juanxiu Huang
Department of Gastroenterology, Wuzhou Red Cross Hospital
Ji Cao
Department of Cancer Prevention and Control Office, The First Affiliated Hospital of Guangxi Medical University
Li Li
Department of Clinical Research, The First Affiliated Hospital, Jinan University
Yanping Fan
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center
Xiaofen Gu
Department of Student Affairs, Affiliated Tumor Hospital, Xinjiang Medical University
Changyan Feng
Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital
Qian Zhu
School of Public Health and Management, Chongqing Medical University
Xiaohui Wang
Department of Public Health, Gansu Provincial Cancer Hospital
Jingchang Du
School of Public Health, Chengdu Medical College
Shaokai Zhang
Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Youlin Qiao
Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Abstract Background The incidence of early-onset colorectal cancer (EOCRC, diagnosed in patients under the age of 50 years) has been increasing around the world. Here, we aimed to systematically identify distinctive features of EOCRC. Methods From 2020 to 2021, we conducted a nationwide survey in 19 hospitals, collecting data on advanced CRC patients’ demographics, clinical features, disease knowledge, medical experiences, expenditures, and health-related quality of life (HRQOL). We compared these features between EOCRC and late-onset colorectal cancer (LOCRC, ≥ 50 years old) groups and analyzed the association between EOCRC and HRQOL using multivariate linear regression. Findings In total, 991 patients with EOCRC and 3581 patients with LOCRC were included. Compared to the LOCRC group, the EOCRC group had higher levels of education, were more informed about the risk factors for CRC, were more likely to have widespread metastases throughout the body, were more inclined to undergo gene testing, and were more likely to opt for targeted therapy, radiotherapy, and chemotherapy. However, HRQOL in the EOCRC group was similar to that of the LOCRC group, and no significant association was observed between EOCRC and HRQOL (beta: -0.753, P value: 0.307). Interpretation In Chinese patients, EOCRC patients had more aggressive features. Despite undergoing more intensified treatments and gene testing, they had similar HRQOL compared with LOCRC. These findings advocate for a more tailored approach to treatment, especially for young CRC patients with advanced TNM stages and metastasis.